comparemela.com

Page 5 - Clinical Cancer Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Breast Cancer: This new customized drug targets and destroys hard-to-treat tumors

Using breast cancer cells' weakness against themselves, UK scientists linked a tumour-selective antibody and developed a cell-killing drug that can destroy hard-to-treat tumours. The findings, published on Wednesday in the journal Clinical Cancer Research, target triple-negative breast cancer

United kingdomClinical cancer research

Breakthrough in breast cancer treatment: This new drug targets and destroys hard-to-treat tumors

Using breast cancer cell s weakness against themselves, UK scientists developed a cell-killing drug that can destroy hard-to-treat tumors.

City ofUnited kingdomSophia karagiannisClinical cancer researchKing college londonCollege londonProfessor sophia karagiannis

Corrections, Retractions Issued for Papers by Dana-Farber Researchers

Several corrections and retractions have been issued for study reports written by researchers at the Dana-Farber Cancer Institute since errors in these and other papers caused some controversy earlier this year. Several corrections and retractions have been issued for study reports written by researchers at the Dana-Farber Cancer Institute.

Barrett rollinsSholto davidClinical cancer researchDana farber cancer instituteCancer researchFor better sciencewrittenNature medicineNature immunologyClinical oncology

Tailored Drug for Aggressive Breast Cancer Developed by Scientists

Tailored Drug for Aggressive Breast Cancer Developed by Scientists
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSimon vincentSophia karagiannisAnthony cheungClinical cancer researchKing college londonCollege londonBreast cancer nowProfessor sophia karagiannis

Immutep s anti-cancer clinical trials advancing rapidly – here are next catalysts for investors

Immutep s anti-cancer clinical trials advancing rapidly – here are next catalysts for investors
theaustralian.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theaustralian.com.au Daily Mail and Mail on Sunday newspapers.

United statesMarc voigtByeddy sunartoMerck coCentre for human drug researchEuropean medicines agencyAmerican society of clinical oncologyFrankfurt institute of clinical cancer researchAmerican societyClinical oncologyEftilagimod alphaFrankfurt instituteClinical cancer researchHuman drug research

vimarsana © 2020. All Rights Reserved.